生物制药行业重大交易频发,默克集团拟30亿美元收购SpringWorks引关注

MedTrend医趋势
11 Feb

2月10日,路透社援引知情人士的话称,默克集团(Merck KGaA)正在就收购美国癌症生物技术公司SpringWorks Therapeutics进行深入谈判,后者市值约为30亿美元。路透社消息人士称,如果一切按计划进行,该协议可能会在未来几周内签署。而关于潜在交易的相关细节,默克集团发言人表示,将在具体实现时公布。此前,默克全球CEO Belen Garijo 曾公开表示,其现有业务的销售增长...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10